In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer

被引:58
作者
Grönberg, H [1 ]
Smith, J
Emanuelsson, M
Jonsson, BA
Bergh, A
Carpten, J
Isaacs, W
Xu, JF
Meyers, D
Trent, J
Damber, JE
机构
[1] Umea Univ, Dept Oncol, S-90185 Umea, Sweden
[2] Umea Univ, Dept Pathol, S-90185 Umea, Sweden
[3] Umea Univ, Dept Urol & Androl, S-90185 Umea, Sweden
[4] Natl Human Genome Res Inst, Prostate Canc Invest Grp, NIH, Bethesda, MD USA
[5] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA
[6] Univ Maryland, Ctr Genet Asthma & Complex Dis, Baltimore, MD 21201 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1086/302447
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Prostate cancer clusters in some families, and an estimated 5%-10% of all cases are estimated to result from inheritance of prostate cancer-susceptibility genes. We previously reported evidence of linkage to the 1q24-25 region (HPC1) in 91 North American and Swedish families each with multiple cases of prostate cancer (Smith et al. 1996). In the present report we analyze 40 (12 original and 28 newly identified) Swedish families with hereditary prostate cancer (HPC) that, on the basis of 40 markers spanning a 25-cM interval within 1q24-25, have evidence of linkage. In the complete set of families, a maximum two-point LOD score of 1.10 was observed at D1S413 (at a recombination fraction [theta] of .1), with a maximum NPL (nonparametric linkage) Z score of 1.64 at D1S202 (P = .05). The evidence of linkage to this region originated almost exclusively from the subset of 12 early-onset (age <65 years) families, which yielded a maximum LOD score of 2.38 at D1S413 (theta = 0) and an NPL Z score of 1.95 at D1S422 (P = .03). Estimates from heterogeneity tests suggest that, within Sweden, as many as 50% of early-onset families had evidence of linkage to the HPC1 region. These results are consistent with the hypothesis of linkage to HPC1 in a subset of families with prostate cancer, particularly those with an early age at diagnosis.
引用
收藏
页码:134 / 140
页数:7
相关论文
共 21 条
[1]   Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43 [J].
Berthon, P ;
Valeri, A ;
Cohen-Akenine, A ;
Drelon, E ;
Paiss, T ;
Wöhr, G ;
Latil, A ;
Millasseau, P ;
Mellah, I ;
Cohen, N ;
Blanché, H ;
Bellané-Chantelot, C ;
Demenais, F ;
Teillac, P ;
Le Duc, A ;
de Petriconi, R ;
Hautmann, R ;
Chumakov, I ;
Bachner, L ;
Maitland, NJ ;
Lidereau, R ;
Vogel, W ;
Fournier, G ;
Mangin, P ;
Cohen, D ;
Cussenot, O .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (06) :1416-1424
[2]   MENDELIAN INHERITANCE OF FAMILIAL PROSTATE-CANCER [J].
CARTER, BS ;
BEATY, TH ;
STEINBERG, GD ;
CHILDS, B ;
WALSH, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3367-3371
[3]   LONGITUDINAL EVALUATION OF PROSTATE-SPECIFIC ANTIGEN LEVELS IN MEN WITH AND WITHOUT PROSTATE DISEASE [J].
CARTER, HB ;
PEARSON, JD ;
METTER, J ;
BRANT, LJ ;
CHAN, DW ;
ANDRES, R ;
FOZARD, JL ;
WALSH, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16) :2215-2220
[4]   Prostate cancer susceptibility locus on chromosome 1q: A confirmatory study [J].
Cooney, KA ;
McCarthy, JD ;
Lange, E ;
Huang, L ;
Miesfeldt, S ;
Montie, JE ;
Oesterling, JE ;
Sandler, HM ;
Lange, K .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (13) :955-959
[5]  
EASTON DF, 1993, AM J HUM GENET, V52, P678
[6]   Linkage analysis of chromosome 1q markers in 136 prostate cancer families [J].
Eeles, RA ;
Durocher, F ;
Edwards, S ;
Teare, D ;
Badzioch, M ;
Hamoudi, R ;
Gill, S ;
Biggs, P ;
Dearnaley, D ;
Ardern-Jones, A ;
Dowe, A ;
Shearer, R ;
McLennan, DL ;
Norman, RL ;
Ghadirian, P ;
Aprikian, A ;
Ford, D ;
Amos, C ;
King, TM ;
Labrie, F ;
Simard, J ;
Narod, SA ;
Easton, D ;
Foulkes, WD ;
Foulkes, WD .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :653-658
[7]  
Gronberg H, 1997, CANCER RES, V57, P4707
[8]  
Gronberg H, 1997, AM J EPIDEMIOL, V146, P552, DOI 10.1093/oxfordjournals.aje.a009313
[9]  
Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO
[10]  
2-5